| The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management A Dignass, G Van Assche, JO Lindsay, M Lémann, J Söderholm, ... Journal of Crohn's and Colitis 4 (1), 28-62, 2010 | 2246* | 2010 |
| 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management F Gomollón, A Dignass, V Annese, H Tilg, G Van Assche, JO Lindsay, ... Journal of Crohn's and Colitis 11 (1), 3-25, 2017 | 2168 | 2017 |
| ECCO guidelines on therapeutics in Crohn's disease: medical treatment J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ... Journal of Crohn's and Colitis 14 (1), 4-22, 2020 | 1039 | 2020 |
| 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 2: surgical management and special situations P Gionchetti, A Dignass, S Danese, FJ Magro Dias, G Rogler, PL Lakatos, ... Journal of Crohn's and Colitis 11 (2), 135-149, 2017 | 773 | 2017 |
| Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and … A Lanas, LA García-Rodríguez, MT Arroyo, F Gomollón, F Feu, ... Gut 55 (12), 1731-1738, 2006 | 736 | 2006 |
| European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases AU Dignass, C Gasche, D Bettenworth, G Birgegård, S Danese, ... Journal of Crohn's and Colitis 9 (3), 211-222, 2015 | 611 | 2015 |
| Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases# C Gasche, A Berstad, R Befrits, C Beglinger, A Dignass, K Erichsen, ... Inflammatory bowel diseases 13 (12), 1545-1553, 2007 | 605 | 2007 |
| Randomized Clinical Trial ofPlantago OvataSeeds (Dietary Fiber) As Compared With Mesalamine in Maintaining Remission in Ulcerative Colitis F Fernandez-Banares, J Hinojosa, JL Sanchez-Lombrana, E Navarro, ... Official journal of the American College of Gastroenterology| ACG 94 (2 …, 1999 | 516 | 1999 |
| ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ... Journal of Crohn's and Colitis 14 (2), 155-168, 2020 | 441 | 2020 |
| Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants A Lanas, LA García-Rodríguez, MT Arroyo, L Bujanda, F Gomollón, ... Official journal of the American College of Gastroenterology| ACG 102 (3 …, 2007 | 395 | 2007 |
| Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients M Chaparro, I Ordás, E Cabré, V Garcia-Sanchez, G Bastida, M Peñalva, ... Inflammatory bowel diseases 19 (7), 1404-1410, 2013 | 322 | 2013 |
| Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review JP Gisbert, F Gomollón Official journal of the American College of Gastroenterology| ACG 103 (7 …, 2008 | 293 | 2008 |
| Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease JP Gisbert, F Gomollón Official journal of the American College of Gastroenterology| ACG 103 (5 …, 2008 | 292 | 2008 |
| Anemia and inflammatory bowel diseases F Gomollón, JP Gisbert World journal of gastroenterology: WJG 15 (37), 4659, 2009 | 288 | 2009 |
| Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis JP Gisbert, PM Linares, AG McNicholl, J Maté, F Gomollón Alimentary pharmacology & therapeutics 30 (2), 126-137, 2009 | 275 | 2009 |
| Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease MJ Casanova, M Chaparro, E Domenech, M Barreiro-de Acosta, ... Official journal of the American College of Gastroenterology| ACG 108 (3 …, 2013 | 262 | 2013 |
| Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ... Nature communications 7 (1), 13507, 2016 | 222 | 2016 |
| ECCO position statement: the use of biosimilar medicines in the treatment of inflammatory bowel disease (IBD) S Danese, F Gomollon, Governing Board and Operational Board of ECCO Journal of Crohn's and Colitis 7 (7), 586-589, 2013 | 213 | 2013 |
| Role of 5-aminosalicylic acid (5-asa) in treatment of inflammatory bowel disease: a systemic review JP Gisbert, F Gomollón, J Maté, JM Pajares Digestive diseases and sciences 47, 471-488, 2002 | 186 | 2002 |
| Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study) MA Montoro, LJ Brandt, S Santolaria, F Gomollon, BS Puértolas, J Vera, ... Scandinavian journal of gastroenterology 46 (2), 236-246, 2011 | 171 | 2011 |
Angel LanasUniversity of Zaragoza. University Clinic Hospital. IIS Aragón. CiberehdVerified email at unizar.es
